Step-wise approach to developing a scale-independent design space for functional tablet coating process

References

• U.S. Department of Health and Human Services. Guidance for Industry: Q8(R2) Pharmaceutical Development [Internet]. Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH); 2009. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20978363
   Google Scholar
• Thomson NM, Seibert KD, Tummala S, et al. Case studies in the applicability of drug substance design spaces developed on the laboratory scale to commercial manufacturing. Org Process Res Dev. 2015;19(8):925–934.
   Web of Science ®Google Scholar
• Harms J, Wang X, Kim T, et al. Defining process design space for biotech products: case study of Pichia pastoris fermentation. Biotechnol Prog. 2008;24(3):655–662.
   PubMed Web of Science ®Google Scholar
• Banerjee A. Designing in quality: approaches to defining the design space for a monoclonal antibody process. BioPharm Int. 2010;23:26–40.
   Web of Science ®Google Scholar
• Hakemeyer C, McKnight N, St. John R, et al. Process characterization and design space definition. Biologicals. 2016;44(5):306–318.
   PubMed Web of Science ®Google Scholar
• Eon-Duval A, Valax P, Solacroup T, et al. Application of the quality by design approach to the drug substance manufacturing process of an Fc fusion protein: towards a global multi-step design space. J Pharm Sci. 2012;101(10):3604–3618.
   PubMed Web of Science ®Google Scholar
• Bergum J, Pfahler L, Senderak E, et al. Statistical considerations in design space development (part II of III). Pharm Technol. 2011;34(8):52–60.
   Google Scholar
• FDA/EMA. Questions and answers on design space verification [Internet]; 2013. Available from: https://www.ema.europa.eu/en/documents/other/questions-answers-design-space-verification_en.pdf
   Google Scholar
• Pisano R, Fissore D, Barresi AA, et al. Quality by design: optimization of a freeze-drying cycle via design space in case of heterogeneous drying behavior and influence of the freezing protocol. Pharm Dev Technol. 2013;18(1):280–295.
   PubMed Web of Science ®Google Scholar
• Fissore D, Pisano R, Barresi AA. Advanced approach to build the design space for the primary drying of a pharmaceutical freeze-drying process. J Pharm Sci. 2011;100(11):4922–4933.
   PubMed Web of Science ®Google Scholar
• Giordano A, Barresi AA, Fissore D. On the use of mathematical models to build the design space for the primary drying phase of a pharmaceutical lyophilization process. J Pharm Sci. 2011;100(1):311–324.
   PubMed Web of Science ®Google Scholar
• Hallow DM, Mudryk BM, Braem AD, et al. An example of utilizing mechanistic and empirical modeling in quality by design. J Pharm Innov. 2010;5(4):193–203.
   Web of Science ®Google Scholar
• Koganti VR, Shalaev EY, Berry MR, et al. Investigation of design space for freeze-drying: use of modeling for primary drying segment of a freeze-drying cycle. AAPS PharmSciTech. 2011;12(3):854–861.
   PubMed Web of Science ®Google Scholar
• Goshima H, Do G, Nakagawa K. Impact of ice morphology on design space of pharmaceutical freeze-drying. J Pharm Sci. 2016;105(6):1920–1933.
   PubMed Web of Science ®Google Scholar
• Mortier S, Van Bockstal PJ, Corver J, et al. Uncertainty analysis as essential step in the establishment of the dynamic design space of primary drying during freeze-drying. Eur J Pharm Biopharm. 2016;103:71–83.
   PubMed Web of Science ®Google Scholar
• Debevec V, Srčič S, Horvat M. Scientific, statistical, practical, and regulatory considerations in design space development. Drug Dev Ind Pharm. 2018;44(3):349–364.
   PubMed Web of Science ®Google Scholar
• Bley O, Siepmann J, Bodmeier R. Protection of moisture-sensitive drugs with aqueous polymer coatings: importance of coating and curing conditions. Int J Pharm. 2009;378(1–2):59–65.
   PubMedGoogle Scholar
• Ruotsalainen M, Heinämäki J, Taipale K, et al. Influence of the aqueous film coating process on the properties and stability of tablets containing a moisture-labile drug. Pharm Dev Technol. 2003;8(4):443–451.
   PubMed Web of Science ®Google Scholar
• Felton LA. Mechanisms of polymeric film formation. Int J Pharm. 2013;457(2):423–427.
   PubMed Web of Science ®Google Scholar
• Ruotsalainen M, Heinämäki J, Guo H, et al. A novel technique for imaging film coating defects in the film-core interface and surface of coated tablets. Eur J Pharm Biopharm. 2003;56(3):381–388.
   PubMed Web of Science ®Google Scholar
• Colorcon. The effect of coating process conditions and coating formula type on the quantity and location of water in film coated tablets [Internet]; 2009. Available from: https://www.colorcon.com/literature/marketing/fc/OpadryII/ads_opadry_II_coat_proc_cond.pdf
   Google Scholar
• Pandey P, Bindra DS, Felton LA. Influence of process parameters on tablet bed microenvironmental factors during pan coating. AAPS PharmSciTech. 2014;15(2):296–305.
   PubMed Web of Science ®Google Scholar
• Pandey P, Bindra DS. Real-time monitoring of thermodynamic microenvironment in a pan coater. J Pharm Sci. 2013;102(2):336–340.
   PubMed Web of Science ®Google Scholar
• Pandey P, Ji J, Subramanian G, et al. Understanding the thermodynamic micro-environment inside a pan coater using a data logging device. Drug Dev Ind Pharm. 2014;40(4):542–548.
   PubMed Web of Science ®Google Scholar
• Melanie M. An introduction to genetic algorithms. A Bradford book. Cambridge (MA): The MIT Press; 1999.
   Google Scholar
• Deb K. An introduction to genetic algorithms. Artif Life. 1999;24(4&5):293–315.
   Google Scholar
• Gabrielsson J, Lindberg NO, Lundstedt T. Multivariate methods in pharmaceutical applications. J Chemometrics. 2002;16(3):141–160.
   Web of Science ®Google Scholar
• Kestur U, Pandey P, Badawy S, et al. Controlling the chemical stability of a moisture-sensitive drug product through monitoring and identification of coating process microenvironment. Int J Pharm. 2014;476(1–2):93–98.
   PubMedGoogle Scholar
• Niblett D, Porter S, Reynolds G, et al. Development and evaluation of a dimensionless mechanistic pan coating model for the prediction of coated tablet appearance. Int J Pharm. 2017;528(1–2):180–201.
   PubMedGoogle Scholar
• Porter SC, Verseput RP, Cunningham CR. Process optimization using design of experiments. Pharm Technol. 1997;21:60–70.
   Google Scholar
• Pourkavoos N, Peck GE. Effect of aqueous film coating conditions on water removal efficiency and physical properties of coated tablet cores containing superdisintegrants. Drug Dev Ind Pharm. 1994;20(9):1535–1554.
   Web of Science ®Google Scholar
• Carlin B, Li J-X, Felton LA. Pseudolatex dispersions for controlled drug delivery. In: Aqueous polymeric coatings for pharmaceutical dosage forms. 3rd ed. Boca Raton (FL): Taylor & Francis Group: CRC Press; 2008. p. 1–46.
   Google Scholar
• Suzzi D, Radl S, Khinast JG. Local analysis of the tablet coating process: impact of operation conditions on film quality. Chem Eng Sci. 2010;65(21):5699–5715.
   Web of Science ®Google Scholar
• Naveršnik K, Bohanec S. Predicting drug hydrolysis based on moisture uptake in various packaging designs. Eur J Pharm Sci. 2008;35(5):447–456.
   PubMed Web of Science ®Google Scholar